Birck A, thor Straten P, Li L, Hou-Jensen K, Sugár J, Zeuthen J
Department of Tumour Cell Biology, Danish Cancer Society, Copenhagen, Denmark.
Melanoma Res. 1997 Feb;7(1):49-57. doi: 10.1097/00008390-199702000-00008.
Spitz naevi and halo naevi are benign melanocytic lesions that share many histological features with malignant melanoma. All lesions are characterized by a brisk infiltration of lymphocytes, mainly of the T cell subtype, and halo naevi are known to undergo spontaneous regression. Since the benign nature of Spitz naevi and halo naevi might therefore be caused by specific T cell responses against tumour-associated antigens, it was found of interest to characterize this T cell response in detail. A reverse transcriptase-polymerase chain reaction (RT-PCR)-based method adapted for analysis of paraffin-embedded material combined with Southern blot analysis has been used to analyse the T cell receptor (TCR) AV and BV repertoires of infiltrating lymphocytes in 14 different melanocytic lesions. The results have shown that only a few particular TCRAV and TCRBV regions are expressed in each lesion. To evaluate the T cell response, it is of interest to know the HLA-type of the analysed lesions, since most melanoma-specific effector lymphocytes are CD8+ cytotoxic T cells and therefore HLA class I-restricted. As blood samples were not available from any of these patients, an RT-PCR method using HLA-A2-specific primers was used to analyse for the presence of this allele. The preferentially expressed TCRAV genes were sequenced, and this analysis showed that the high expression of these TCRAV genes was due to a clonal or oligocional expansion of T cells. In summary, the expression of relatively few TCR variable regions indicates a clonal expansion of T cells.
斯皮茨痣和晕痣是良性黑素细胞性病变,与恶性黑色素瘤有许多组织学特征相同。所有病变的特征都是淋巴细胞的活跃浸润,主要是T细胞亚型,并且已知晕痣会自发消退。由于斯皮茨痣和晕痣的良性性质可能是由针对肿瘤相关抗原的特异性T细胞反应引起的,因此详细表征这种T细胞反应很有意义。一种基于逆转录酶-聚合酶链反应(RT-PCR)的方法,适用于分析石蜡包埋材料并结合Southern印迹分析,已被用于分析14种不同黑素细胞性病变中浸润淋巴细胞的T细胞受体(TCR)AV和BV谱系。结果表明,每个病变中仅表达少数特定的TCRAV和TCRBV区域。为了评估T细胞反应,了解所分析病变的HLA类型很有意义,因为大多数黑色素瘤特异性效应淋巴细胞是CD8 +细胞毒性T细胞,因此受HLA I类限制。由于这些患者均未提供血样,因此使用一种使用HLA-A2特异性引物的RT-PCR方法来分析该等位基因的存在。对优先表达的TCRAV基因进行测序,该分析表明这些TCRAV基因的高表达是由于T细胞的克隆或寡克隆扩增。总之,相对较少的TCR可变区的表达表明T细胞的克隆扩增。